ASHLEY LONG: Open Payments
NPI 1073078648 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 19 payments from 7 companies in 2025. Trend: 2023 $813 · 2024 $493 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Alnylam Pharmaceuticals Inc. | 3 | $49 |
| AtriCure, Inc. | 2 | $45 |
| Philips North America LLC | 2 | $33 |
| BridgeBio Pharma, Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $29 |
Products named: LEQVIO, CAMZYOS, AMVUTTRA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Attruby, AVEIR, Extended Holter, LM Undivided.
Industry payments across AR — which companies pay providers there.
